Recombinant Human Fibrillarin [His]

This research paper introduces an outline of a simplified version of single-input neuro-fuzzy controller (NFC) method via a decoupling-controlled intuitive feedback linearization (FBL) approach of induction motor (IM) model. The proposed NFC with FBL extensively reduces the torque and speed ripple along with better performance enhancement. A simplified state-space feedback linearization technique-based nonlinear IM model is designed and simulated in the stationary reference frame. Again, the parameter and plant uncertainties in the feedback-linearized model of the IM are continuous phenomenon which led to the design of a robust, simplified NFC to overcome these issues in the real-time industrial application. The proposed reduced membership function (MF) based simplified NFC is the integration of fuzzy logic and neural network concept with single input as an error (speed and torque) unlike two inputs error and change in error of conventional NFC. This has the advantage of improving the computational efficiency due to its simple structure and robustness over conventional NFC. This makes the system easy and simple to implement in a realistic situation. The performance and effectiveness of the proposed method using FBL concept of IM drive is analyzed using MATLAB software in different modes of operation and is distinguished with the conventional PI-controller and conventional NFC to show its superiority. The proposed system with the different control strategies is also validated by extensive experimental results using DSP 2812.

Heterogeneity of V-alpha-1+ and V-beta-10+ TCR alpha-beta-chains, which are predominantly used in anti-FBL-3 CTL clones established in vitro, was investigated at a nucleotide level in FBL-3 tumor-infiltrating lymphocytes (TIL) in vivo. The majority (90%) of V-beta-10+ beta-chains dominated in TIL used homogeneous V-beta-10D-beta-2.1 sequences identical to that used in the T cell clones with cytotoxic functions. The homogeneous TCR beta-chain expression was dominant and found to be about 10% of the total TCR beta-chains in the TIL population, which was a > 300- to 900-fold increase than in the regional lymph nodes. This is in good agreement with the in vitro data showing that about 11% CTL clones used the homogeneous V-beta-10D-beta-2.1+ beta-chain. However, the J-beta segment does not seem to contribute greatly to the recognition and selection of this TCR because some of homogeneous VD+ beta-chains were associated with J-beta segments other than J-beta-2.7 of the CTL clones. The frequency of the V-alpha-1J-alpha-112-2+ alpha-chain expression of the CTL type was much less (3- to 80-fold increase compared to that of lymph node) and also varied in sample materials, indicating the lower contribution of the alpha-chain for the oligoclonality of the TCR. The results were also confirmed by quantitative PCR and RNase protection assays. This suggests that the dominant expression of the homogeneous TCR beta-chain is due to the expansion of the particular anti-FBL-3 CTL in the tumor in situ. Also, the TCR beta-chain, especially the V-beta-D-beta region, rather than alpha-chain is more important for the recognition and selection of the anti-FBL-3 TIL with cytotoxic functions.